|
Volumn 5, Issue 1, 1999, Pages 64-65
|
Lack of current clinical value of serological testing in the evaluation of patients with IBD
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
FUNGUS ANTIBODY;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
CLINICAL TRIAL;
CROHN DISEASE;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
IMMUNOLOGY;
PROGNOSIS;
REVIEW;
SACCHAROMYCES CEREVISIAE;
SENSITIVITY AND SPECIFICITY;
SEROLOGY;
ULCERATIVE COLITIS;
ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC;
ANTIBODIES, FUNGAL;
BIOLOGICAL MARKERS;
CLINICAL TRIALS;
COLITIS, ULCERATIVE;
CROHN DISEASE;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
PROGNOSIS;
SACCHAROMYCES CEREVISIAE;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
|
EID: 0033072501
PISSN: 10780998
EISSN: None
Source Type: Journal
DOI: 10.1097/00054725-199902000-00009 Document Type: Short Survey |
Times cited : (16)
|
References (6)
|